207 related articles for article (PubMed ID: 29627705)
21. Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer.
Orfanou IM; Argyros O; Papapetropoulos A; Tseleni-Balafouta S; Vougas K; Tamvakopoulos C
Front Oncol; 2021; 11():608201. PubMed ID: 33842315
[TBL] [Abstract][Full Text] [Related]
22. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer.
von Arx C; De Placido P; Caltavituro A; Di Rienzo R; Buonaiuto R; De Laurentiis M; Arpino G; Puglisi F; Giuliano M; Del Mastro L
Cancer Treat Rev; 2023 Feb; 113():102500. PubMed ID: 36587473
[TBL] [Abstract][Full Text] [Related]
23. Nontoxic Fluorescent Nanoprobes for Multiplexed Detection and 3D Imaging of Tumor Markers in Breast Cancer.
Sokolov P; Nifontova G; Samokhvalov P; Karaulov A; Sukhanova A; Nabiev I
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986807
[TBL] [Abstract][Full Text] [Related]
24. Potential Biomarkers Associated with Prognosis and Trastuzumab Response in HER2+ Breast Cancer.
Castro-Guijarro AC; Sanchez AM; Flamini MI
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686651
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Characterization of Anti-HER2 Antibody Conjugated CdSe/CdZnS Quantum Dots for Fluorescence Imaging of Breast Cancer Cells.
Tiwari DK; Tanaka S; Inouye Y; Yoshizawa K; Watanabe TM; Jin T
Sensors (Basel); 2009; 9(11):9332-64. PubMed ID: 22291567
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture.
Rodríguez CE; Berardi DE; Abrigo M; Todaro LB; Bal de Kier Joffé ED; Fiszman GL
J Cell Biochem; 2018 Feb; 119(2):1381-1391. PubMed ID: 28722778
[TBL] [Abstract][Full Text] [Related]
27. [Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer].
Kolyadina IV; Zavalishina LE; Ganshina IP; Andreeva YY; Frank GA; Gordeeva OO; Zhukova LG; Meshcheryakov AA; Savelov NA; Tuzova EA; Morozov DA; Poddubnaya IV
Arkh Patol; 2019; 81(6):56-62. PubMed ID: 31851193
[TBL] [Abstract][Full Text] [Related]
28. Purified fluorescent nanohybrids based on quantum dot-HER2-antibody for breast tumor target imaging.
Yao F; Wang ZG; Liu SL; Wang H; Zhu J; He R; Yang X; Liu X; Wu Q; Wu JK
Talanta; 2023 Aug; 260():124560. PubMed ID: 37116362
[TBL] [Abstract][Full Text] [Related]
29. Tumor uptake and tumor/blood ratios for [
Al-Saden N; Cai Z; Reilly RM
Nucl Med Biol; 2018 Dec; 67():43-51. PubMed ID: 30390575
[TBL] [Abstract][Full Text] [Related]
30. β-catenin promotes resistance to trastuzumab in breast cancer cells through enhancing interaction between HER2 and SRC.
Hao X; Zheng J; Yu X; Li Z; Ren G
Acta Biochim Pol; 2023 Apr; 70(2):261-269. PubMed ID: 37331014
[TBL] [Abstract][Full Text] [Related]
31. On-chip multiplexed solid-phase nucleic acid hybridization assay using spatial profiles of immobilized quantum dots and fluorescence resonance energy transfer.
Noor MO; Tavares AJ; Krull UJ
Anal Chim Acta; 2013 Jul; 788():148-57. PubMed ID: 23845494
[TBL] [Abstract][Full Text] [Related]
32. Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer.
Sun JZ; Chen C; Jiang G; Tian WQ; Li Y; Sun SR
Int J Nanomedicine; 2014; 9():1339-46. PubMed ID: 24648732
[TBL] [Abstract][Full Text] [Related]
33. Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity.
Houdaihed L; Evans JC; Allen C
Pharm Res; 2020 Jan; 37(3):39. PubMed ID: 31965330
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
Chan C; Fonge H; Lam K; Reilly RM
Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
[TBL] [Abstract][Full Text] [Related]
35. Quantum dots-based double-color imaging of HER2 positive breast cancer invasion.
Liu XL; Peng CW; Chen C; Yang XQ; Hu MB; Xia HS; Liu SP; Pang DW; Li Y
Biochem Biophys Res Commun; 2011 Jun; 409(3):577-82. PubMed ID: 21609713
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
